Trending Now
ASCO 2019
Daiichi Sankyo to Presents ADC Pipeline Results
Data for several investigational compounds in the Daiichi Sankyo oncology pipeline will be presented at the upcomming annual meeting of the American Society of...
Phase I Data for SAR408701 Supports Further Development in Lung Cancer
During the upcoming annual meeting American Society of Clinical Oncology (ASCO) in June 2019, Sanofi's oncology franchise will present a renewed strategy to address...
PEER REVIEW
EDITORIAL
Understanding of the Underlying Mechanisms of Target-Independent Uptake and Toxicity
With 4 approved agents, antibody-drug conjugates or ADC have shown to be a very promising class of therapeutics. While the concept of ADCs is not...
How Meaningful Will Changes Be to Ethical Guidelines Following Jose Baselga’s...
In the aftermath of the fall of renowned breast cancer researcher Jose Baselga, MD, PhD, following revelations last month of his failure to disclose...
